Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18463125 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C Vaccine
Conditions: Haemophilus Influenzae Type b;   Neisseria Meningitidis
Intervention: Biological: Haemophilus influenzae type b- and meningococcal (vaccine)

Indicates status has not been verified in more than two years